ArticleAmerican journal of clinical dermatology2026
Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
Brett King et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.